MRNA Moderna, Inc.

Mentions (100)

• 4chan /biz/biz·15h ago·Positive

  should i be buying MRNA in advance of the new black plague

  View source ↗
• News247wallst.com·19h ago·Negative

  Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are trading as though the company's messenger RNA (mRNA) cancer vaccine has already cleared its final test, even though the complete Phase 3 dataset has yet to be presented publicly.

  View source ↗
• News (Marketaux)insidermonkey.com·1d ago·Positive

  Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running? Moderna Inc. (NASD[+249 characters]

  View source ↗
• News (RSS)seekingalpha·2d ago·Positive

  Moderna, Illumina lead healthcare gains in September as medtech drags

  View source ↗
• News (RSS)zerohedge·3d ago·Neutral

  …collaboration agreement with independent Spanish streamer Filmin. Twilio will replace Warner Bros Discovery in the S&P 500, Vylor replaces Corteva in the S&P 500 and Moderna replaces Warner Bros Discovery in the Nasdaq 100. Nike is cutting jobs and embarking on a sweeping overhaul of its business as results deteriorate, a restructuring plan that it said will save $2.5 billion over the next five years. The FHFA is said to be planning to direct Fannie Mae and Freddie Mac within weeks to require le…

  View source ↗
• Newsseekingalpha.com·4d ago·Negative

  Wall Street Breakfast Podcast: No Sprint For Nike Yet Nike (NKE) faces persistent headwinds, with Q1 sales down 4% and China revenue plunging 22% year-over-year. Moderna (MRNA) will join the Nasdaq-100 replacing Warner Bros Discovery (WBD).

  View source ↗
• Newsinvezz.com·4d ago·Neutral

  Moderna stock rises 2% on Nasdaq 100 entry but this analyst says sell Moderna stock (NASDAQ: MRNA) rose more than 2% in early premarket trading on Friday after Nasdaq said the biotech company will join the Nasdaq-100 next week, creating new demand from index-tracking funds. The move follows a spectacular 2026 rally that has pushed Moderna more than 500% higher and transformed it from a post-pandemic recovery story into an oncology bet.

  View source ↗
• Newsbarrons.com·4d ago·Neutral

  Nike, ON Semi, Moderna, and More Stocks That Explain Today's Market Nike slumps after the retailer misses analysts' first-quarter earnings target and issues downbeat full-year guidance.

  View source ↗
• News (RSS)seekingalpha·4d ago·Neutral

  Moderna to join Nasdaq-100, replacing Warner Bros. Discovery

  View source ↗
• News (RSS)investing·4d ago·Neutral

  Moderna to replace Warner Bros Discovery on Nasdaq 100

  View source ↗
• News (Marketaux)manilatimes.net·4d ago·Neutral

  Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE)[+271 characters]

  View source ↗
• Newsreuters.com·4d ago·Neutral

  Moderna to replace Warner Bros Discovery  on Nasdaq 100 Nasdaq ​said on Thursday ‌that vaccine maker Moderna will replace Warner ​Bros. Discovery on ​the Nasdaq 100 index , ⁠effective October 9.

  View source ↗
• Newsglobenewswire.com·4d ago·Neutral

  Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Moderna, Inc. (Nasdaq: MRNA) will become a component of the Nasdaq-100 Index® (NDX®) replacing Warner Bros. Discovery, Inc. (Nasdaq: WBD) prior to market open on Friday, October 9, 2026.

  View source ↗
• Newszacks.com·4d ago·Positive

  Moderna (MRNA) Stock Dips While Market Gains: Key Facts Moderna (MRNA) closed the most recent trading day at $188.94, moving 1.89% from the previous trading session.

  View source ↗
• News247wallst.com·4d ago·Negative

  Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water Buyers are stepping into Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares, evidently. The move comes one session after a Citigroup (NYSE:C) downgrade to Sell, a sign the market still prizes the company's cancer vaccine pipeline over the valuation warning.

  View source ↗
• News (RSS)fool·5d ago·Negative

  Prediction: Moderna Stock Will Soar 100% by 2030 The company could enter a fresh growth phase.

  View source ↗
• Newsinvestopedia.com·5d ago·Neutral

  Moderna Stock Slumps as Citi Says It's Time to Sell After 500% Rally This Year Moderna's stock has been flying high lately. That has one group of analysts saying it's time to sell.

  View source ↗
• Newsbenzinga.com·5d ago·Positive

  Moderna Shares Reverse Weakness, Rise Over 3% After Key Trading Signal Moderna Inc. (NASDAQ:MRNA) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.

  View source ↗
• Newsbenzinga.com·5d ago·Neutral

  What's Going On With Moderna Stock on Wednesday? Moderna Inc. (NASDAQ:MRNA) stock is trading lower on Wednesday after the company added a Chief Operating Officer role to support the increasing scale and diversification.

  View source ↗
• Newszacks.com·5d ago·Positive

  Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? MRNA's respiratory vaccine expansion and promising oncology results offer potential growth as COVID-19 demand normalizes.

  View source ↗
• News (RSS)forbes·5d ago·Neutral

  Moderna Shares Slump As Citi Downgrades To 'Sell’ After Cancer Vaccine Rally Moderna stock has rallied more than 200% since August, following positive Phase 3 trial results for a melanoma vaccine.

  View source ↗
• News (Marketaux)gurufocus.com·5d ago·Positive

  Moderna (MRNA) Names Juan Andres as COO to Drive Oncology and Infectious Disease Growth On September 30, 2026, Moderna [+149 characters]

  View source ↗
• Newsbarrons.com·5d ago·Neutral

  Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter Moderna stock has rallied since the company unveiled clinical updates to its cancer vaccine in collaboration with Merck in late August.

  View source ↗
• News (RSS)seekingalpha·5d ago·Neutral

  Moderna names Juan Andres chief operating officer

  View source ↗
• News247wallst.com·6d ago·Negative

  Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is drawing attention Wednesday after Citigroup downgraded the biotech company to Sell from Hold, arguing that the recent rally has pushed the valuation well ahead of what its pipeline can reasonably support.

  View source ↗
• Newsinvezz.com·6d ago·Negative

  Moderna stock falls 6% in premarket: here's why Moderna stock MRNA fell nearly 6% in premarket trading on Wednesday after Citi downgraded the biotech company to ‘Sell' from ‘Hold', citing concerns that its recent valuation is difficult to justify. Citi raised its price target to $80 from $60 while revising its sales and operating expense assumptions.

  View source ↗
• Newsbarrons.com·6d ago·Negative

  Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell. Citi downgrades Moderna to Sell from Hold, saying the data around its cancer vaccine, instimeran autogene, isn't enough to justify the valuation.

  View source ↗
• Newsmarketwatch.com·6d ago·Neutral

  Citi tells investors it's time to sell Moderna after 600%-plus stock gains Revenue and profit forecasts fail to justify the hype baked into Moderna's share price, according to Citi's analysts.

  View source ↗
• Newsaccessnewswire.com·6d ago·Neutral

  …f Operating Officer Jerh Collins to Retire Following Four Years of Leadership at Moderna CAMBRIDGE, MA / ACCESS Newswire / September 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the addition of a Chief Operating Officer role to support the increasing scale and diversification of the Company. The new role comes as Moderna prepares for the potential launch and scale-up of intismeran autogene following positive Phase 3 results and continues to advance a broader oncology portfolio.

  View source ↗
• News (RSS)seekingalpha·6d ago·Neutral

  Moderna And Merck: The Intismeran Readout That Was Worth $86 Billion

  View source ↗
• Newsbenzinga.com·6d ago·Positive

  Moderna Sets Another Fresh 52-Week High: What's Happening? Moderna Inc. (NASDAQ:MRNA) shares are climbing again Tuesday, touching a fresh 52-week high of $208.90 just days after clearing its previous record on strong clinical trial news.

  View source ↗
• News (Marketaux)gurufocus.com·8d ago·Positive

  Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on September 27, 2026 On September 27, 2026, Moderna [+276 characters]

  View source ↗
• Newszacks.com·10d ago·Neutral

  Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing Moderna (MRNA) concluded the recent trading session at $198.88, signifying a +2.08% move from its prior day's close.

  View source ↗
• 4chan /biz/biz·10d ago·Negative

  Moderna 200 Celebration post WOOOHOOO https://youtu.be/3GwjfUFyY6M?is=FYLEKBlaVcWkt1hG They f****** cured cancer

  View source ↗
• News (RSS)wsj·11d ago·Neutral

  Moderna CEO’s Realistic Approach to Innovation

  View source ↗
• 4chan /biz/biz·11d ago·Positive

  Moderna is going to the freaking moon. 200 Soon™

  View source ↗
• 4chan /biz/biz·11d ago·Positive

  MRNA pumping good

  View source ↗
• News (RSS)seekingalpha·12d ago·Positive

  Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript

  View source ↗
• News (RSS)businessinsider·12d ago·Neutral

  YieldMax MRNA Option Income Strategy ETF declares $0.6367 dividend

  View source ↗
• 4chan /biz/biz·12d ago·Negative

  Moderna is losing steam. Cmom baby push push push. Lets hit the magical 200. Push Push Push its almost there.

  View source ↗
• 4chan /biz/biz·12d ago·Neutral

  Moderna it keeps going. 200 Soon

  View source ↗
• 4chan /biz/biz·12d ago·Neutral

  Come on MRNA, it's all up to you now

  View source ↗
• Newsbarrons.com·12d ago·Negative

  Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker Is Going Next Moderna stock heads for its highest close since 2023 after CEO Stéphane Bancel says the drugmaker ‘has never been' just a Covid vaccine company.

  View source ↗
• Newsseekingalpha.com·12d ago·Positive

  Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript

  View source ↗
• Newsmarketbeat.com·12d ago·Neutral

  Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID Moderna NASDAQ: MRNA executives emphasized the company's evolution beyond COVID-19 vaccines during a discussion with Bernstein, highlighting its mRNA platform, personalized cancer vaccine program intismeran, rare-disease pipeline and plans to expand therapeutics development.

  View source ↗
• 4chan /biz/biz·13d ago·Negative

  Why did I listen to you guys and sell MRNA

  View source ↗
• Newsfool.com·13d ago·Positive

  Is Moderna Stock a Buy After Its Melanoma Breakthrough? Moderna (MRNA +5.87%) may finally have the catalyst investors have been waiting for beyond COVID. A successful Phase 3 melanoma study strengthens the case for personalized mRNA cancer treatment, but the stock's huge rerating now leaves one question dominant: Can this become a durable oncology franchise, or has the market moved faster than the evidence?

  View source ↗
• News247wallst.com·13d ago·Positive

  Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up? Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are rallying again as investors position ahead of a late-October data drop that could validate the first personalized cancer therapy tested at scale. Moderna stock is at $181.

  View source ↗
• Newszacks.com·14d ago·Positive

  MRNA Hits 52-Week High: How Melanoma Study Results Keep Rally Going Moderna's 52-week high follows positive melanoma results, with detailed phase III data set for an ESMO presentation.

  View source ↗
• News (RSS)marketwatch·14d ago·Neutral

  Moderna to reveal data for its mRNA cancer vaccine next month. Why that matters.

  View source ↗
• News (RSS)marketwatch·14d ago·Neutral

  Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters. One reason that analysts and doctors want to see the data is to better understand how well the personalized treatment works.

  View source ↗
• News (RSS)yahoo·14d ago·Neutral

  Moderna (MRNA) Soars to Fresh High Ahead of Pipeline Updates This Week

  View source ↗
• News (RSS)investing·14d ago·Neutral

  Moderna stock hits 52-week high at 176.75 USD

  View source ↗
• 4chan /biz/biz·14d ago·Neutral

  >>62712554 >Moderna Baggies they literally cured every cancer

  View source ↗
• 4chan /biz/biz·14d ago·Neutral

  Moderna Baggies there is your exit if you want it.

  View source ↗
• 4chan /biz/biz·14d ago·Neutral

  Moderna Go baby go baby Go Up up up to 200.

  View source ↗
• 4chan /biz/biz·14d ago·Neutral

  Moderna 170 now. Yeah im thinking its going to 200 soon. Its a f****** fiesta Lets f****** GOOOOOOOOO: http://www.youtube.com/watch?v=FwHU32HL3SE

  View source ↗
• 4chan /biz/biz·14d ago·Neutral

  Moderna its fuccking going again. I wish i had bought more at 130. Might even go to offset the baggies who boight at 170.

  View source ↗
• Newsbenzinga.com·14d ago·Neutral

  Moderna Stock Is Soaring: What's Going On? Moderna Inc. (NASDAQ:MRNA) shares are surging Monday. The company announced three abstracts on its personalized cancer vaccine intismeran autogene were accepted for presentation at the European Society for Medical Oncology Congress.

  View source ↗
• News247wallst.com·14d ago·Negative

  Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares are surging Monday morning after the company announced that its Phase 3 adjuvant melanoma study for intismeran autogene, an investigational messenger RNA individualized neoantigen therapy, was selected for a Presidential Symposium slot at

  View source ↗
• Newsaccessnewswire.com·15d ago·Positive

  …ost an investor event via webcast on Saturday, October 24, at 7:00 PM CEST / 1:00 PM EDT CAMBRIDGE, MA / ACCESS Newswire / September 21, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on intismeran autogene, an investigational mRNA-based individualized neoantigen therapy, have been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026, which will be held October 23-27 in Madrid, Spain. The presentation details are as follows: Preside…

  View source ↗
• News (Marketaux)finance.yahoo.com·16d ago·Neutral

  Dow Jones Futures: Nasdaq, S&P 500 Hold; Robinhood, Sandisk, AMD, Moderna Surge Into Buy Areas Dow Jones Futures: Nasdaq, S&P 500 Hold; Robinhood, Sandisk, AMD, Moderna Surge Into Buy Areas

  View source ↗
• News (RSS)fool·17d ago·Neutral

  Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026? One company is growing a commercial drug business with limited margin for error on the path to profitability. The other has a platform that proved itself at global scale and keeps finding new diseases to target.

  View source ↗
• Newsfool.com·17d ago·Positive

  Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026? Axsome Therapeutics is seeing significant revenue growth as its central nervous system portfolio gains commercial traction. Moderna is transitioning its mRNA platform toward a broader array of respiratory and oncology treatments to offset declining COVID-19 vaccine sales.

  View source ↗
• News (RSS)yahoo·18d ago·Positive

  Moderna: Another Day, Another Big Stock Move. Is the Cancer Vaccine Rally Back On?

  View source ↗
• 4chan /biz/biz·18d ago·Negative

  >>62700648 no. I don't touch anything biopharma personally, except to short large names like Moderna after somebody agrees to pay 3x what someone else paid 24 hours earlier for 1 stock of it. Because the risk of such a play with that setup is relatively low in my opinion

  View source ↗
• 4chan /biz/biz·18d ago·Neutral

  Look at Moderna go. Very nice.

  View source ↗
• Newsbenzinga.com·18d ago·Positive

  Moderna Stock Is Surging: What's Going On? Moderna Inc. (NASDAQ:MRNA) shares are popping Thursday, extending a month-long rally that began with a Phase 3 cancer vaccine breakthrough.

  View source ↗
• News247wallst.com·19d ago·Negative

  Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher Cancer vaccine momentum is doing the work for Moderna (NASDAQ:MRNA | MRNA Price Prediction) once again on Thursday, extending one of the sharpest one-month runs in large-cap biotech this year without a fresh disclosure attached to it.

  View source ↗
• Newsdefenseworld.net·20d ago·Negative

  Moderna (NASDAQ:MRNA) Shares Down 2% on Insider Selling Moderna, Inc. (NASDAQ: MRNA - Get Free Report)'s share price was down 2% during mid-day trading on Tuesday following insider selling activity. The company traded as low as $141.16 and last traded at $143.77. 8,229,730 shares traded hands during mid-day trading, a decline of 29% from the average daily volume of 11,597,177 shares. The stock had

  View source ↗
• Newszacks.com·20d ago·Negative

  Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID? Shares of Moderna MRNA have staged a remarkable comeback this year as investors increasingly warm to the possibility that the company can rebuild its business beyond COVID-19 vaccines. After becoming one of the biggest pandemic winners, Moderna struggled with sharply lower COVID-19 vaccine demand, declining revenues and mounting losses, sending its stock tumbling from its pandemic-era highs.

  View source ↗
• Newszacks.com·21d ago·Negative

  Moderna (MRNA) Ascends While Market Falls: Some Facts to Note In the closing of the recent trading day, Moderna (MRNA) stood at $146.69, denoting a +1.89% move from the preceding trading day.

  View source ↗
• Newspymnts.com·21d ago·Negative

  Moderna's AI-Built Cancer Vaccine Clears Phase 3 With Merck Moderna built an artificial intelligence that reads a patient's tumor and decides what that patient's medicine should be. That approach just cleared its biggest test.

  View source ↗
• News (RSS)seekingalpha·21d ago·Negative

  The Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both Sell

  View source ↗
• Newsseekingalpha.com·21d ago·Positive

  Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

  View source ↗
• Newsmarketbeat.com·21d ago·Neutral

  Moderna's Cancer Vaccine Win Fuels Broad Push Across Tumor Types Moderna NASDAQ: MRNA President Stephen Hoge said the company's recently announced positive Phase III results for its investigational personalized cancer vaccine, intismeran, in adjuvant melanoma support a broader effort to use T-cell priming in multiple tumor types.

  View source ↗
• 4chan /biz/biz·22d ago·Neutral

  >>62686279 >buying the news Oh no no See I'm kinda decent at catching falling knives. JNJ is already frontran. Unless they do a MRNA and come out with a cure for cancer, they aren't going much further up. NVO on the other hand is fudded to hell just because their fat loss product is slightly worse than Lilly's. These fat loss pills will just keep getting better with less side effects and people will put more trust on known brands intead of buying Indian generics. Only a matter of time before NVO…

  View source ↗
• News (RSS)yahoo·23d ago·Positive

  Dow Jones Futures: Fed Rate Hike Seen As Oil, Yields Pressure Stocks; Apple, Moderna Are New Buys

  View source ↗
• 4chan /biz/biz·24d ago·Negative

  Moderna still swingwing wildly for no readon it seems. If i had liquidity i would have entered at 130 yesterday again.

  View source ↗
• News247wallst.com·24d ago·Negative

  Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is up 8% to $147.37 in Friday morning trading, a sharp single-name move on a session when biotech as a group is quiet and broader U.S. equities are only modestly higher.

  View source ↗
• News (RSS)fool·25d ago·Positive

  Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026? Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.

  View source ↗
• Newszacks.com·27d ago·Neutral

  MRNA Stock Soars 143% in a Month: Time to Buy, Hold or Sell? Moderna stock surges 143% in a month on positive cancer therapy results, but competition and valuation raise key questions for investors.

  View source ↗
• 4chan /biz/biz·29d ago·Neutral

  >>62666162 SNDK MRNA DELL MU STX WDC MRVL INTC MPC LITE

  View source ↗
• News (Marketaux)gurufocus.com·29d ago·Neutral

  MRNA Looks 503.7% Overvalued on GF Value™ On September 06, 2026, Moderna [+165 characters]

  View source ↗
• Newsyoutube.com·29d ago·Neutral

  Moderna cancer vaccine BREAKTHROUGH drives new hope after phase 3 trial Moderna co-founder and board chairman Noubar Afeyan discusses the phase three success of the Moderna-Merck cancer vaccine trial and explains how the vaccine targets unique mutations to help prevent melanoma recurrence on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #moderna #merck #cancer #vaccine #health #medicine #medical #melanoma #science #research #tria…

  View source ↗
• Newsmarketbeat.com·30d ago·Negative

  Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It Drug pricing is back on the front page, and healthcare investors have barely flinched. The White House's latest round of most-favored-nation pricing agreements brought nine more manufacturers into the fold, pushing the total to 26 companies covering 89% of the branded drug market.

  View source ↗
• Newsfool.com·30d ago·Neutral

  If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.) Moderna has had great success with its mRNA technology used for vaccines. Its promising trial results for a cancer vaccine have many investors excited.

  View source ↗
• News (Marketaux)gurufocus.com·30d ago·Positive

  MRNA Looks 503.4% Overvalued on GF Value™ Moderna Inc (NASDA[+140 characters]

  View source ↗
• News (RSS)seekingalpha·30d ago·Neutral

  Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks

  View source ↗
• News (RSS)zerohedge·31d ago·Neutral

  …re the control and keep revealing that there might be a better way. Eliminate the control and you eliminate the embarrassment. This is precisely what both Pfizer and Moderna did after their own tests of the COVID shot: they pushed it on the saline group following first results. In Pennsylvania, opposition arose to this push for industrial inoculation, and understandably so. In the post-COVID era, trust in public health is depleted to near zero. Here is where the current drama picked up. On Aug. …

  View source ↗
• News (RSS)fool·31d ago·Neutral

  Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run? The vaccine maker is making an increasingly robust case that it isn't just a pandemic stock.

  View source ↗
• News (RSS)barrons·32d ago·Neutral

  The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels. Tempus AI could capture a lucrative slice of Moderna and Merck’s personalized cancer therapy business, with Personalis at the center of the bet.

  View source ↗
• News (RSS)wsj·32d ago·Neutral

  The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels. Tempus AI could capture a lucrative slice of Moderna and Merck’s personalized cancer therapy business, with Personalis at the center of the bet.

  View source ↗
• News (RSS)yahoo·32d ago·Positive

  BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?

  View source ↗
• Newsfxempire.com·32d ago·Positive

  Moderna (MRNA) Price Forecast: Bullish Pennant Points Toward Higher Targets Moderna consolidates after a dramatic breakout, with a bullish pennant forming near resistance and offering a potential signal for another powerful advance.

  View source ↗
• News (RSS)seekingalpha·32d ago·Neutral

  Moderna slips as Rothschild issues rare Sell rating after cancer vaccine-led rally

  View source ↗
• Newszacks.com·32d ago·Neutral

  Does Moderna's mRNA Flu Shot Face a New Challenge From GSK? MRNA's newly approved mFlusiva faces a potential challenge as GSK advances an mRNA flu vaccine targeting two viral proteins.

  View source ↗
• Newsbarrons.com·32d ago·Neutral

  Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating Rothschild analyst Simon Baker downgrades Moderna stock to Sell from Neutral while doubling his price target.

  View source ↗
• Newsseekingalpha.com·33d ago·Neutral

  Moderna: Massive Asymmetry About What The mRNA Is! Moderna receives a speculative Strong Buy rating after phase 3 melanoma data strengthens its oncology platform thesis. MRNA's upside hinges on Intismeran's ability to scale across multiple tumor types, not just melanoma. The 50/50 partnership with Merck provides both distribution strength and shared economics for Intismeran.

  View source ↗
• News (RSS)yahoo·33d ago·Negative

  Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to Run

  View source ↗